论文信息 - Phase I and Pharmacokinetic Study ofTasidotin Hydrochloride ( ILX 651 ) , aThird-Generation Dolastatin-15 Analogue , AdministeredWeekly for 3 Weeks Every 28 Days in Patients with Advanced SolidTumors - 字舞流文

Phase I and Pharmacokinetic Study ofTasidotin Hydrochloride ( ILX 651 ) , aThird-Generation Dolastatin-15 Analogue , AdministeredWeekly for 3 Weeks Every 28 Days in Patients with Advanced SolidTumors

P. Bonate | A. Mita | E. Rowinsky | L. Hammond | Q. Chu | C. Jones | S. Syed | J. Debono | M. Garrison | GeoffreyWeiss | HeatherMcCreery | SteveWeitman